文献速递乳腺MR

MRI对高级别导管原位癌管理的影响:我们是否充分发挥了MRI的作用

Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI?
PubMed 文献 · Eur J Radiol · 2017-08-31

研究评估术前MRI对高级别导管原位癌手术管理的影响。91例MRI组与52例对照组比较,MRI组再切除率8%低于对照组26%(P=0.012),MRI使9例(13%)由保乳转为乳房切除,发现5例(7%)同侧额外恶性特征和2例(3%)对侧隐匿癌。作者认为MRI可能有助于降低再切除率,选择性MRI可能有用,需MDT逐例讨论。

要点

  • MRI组再切除或补行乳房切除率8%,低于对照组26%(P=0.012)。
  • MRI使9例(13%)初始保乳计划正确转为乳房切除。
  • MRI检出同侧额外恶性特征5例(7%)、对侧隐匿癌2例(3%)。

核心结论

  • 本研究提示MRI可能是降低高级别导管原位癌手术再切除率的重要工具。
  • 尽管仍有争议,选择性MRI成像可能有助于高级别导管原位癌的术前诊断与评估。
  • 多学科团队(MDT)逐例讨论至关重要。
  • 在有指征时更广泛地应用MRI评估乳腺病变,并与术后组织学正确对照,是提高MRI判读能力、充分发挥该工具有用价值的关键。

研究设计与样本

  • 研究类型为在Kettering General Hospital前瞻性收集数据中识别连续病例的对比研究,MRI组91例,对照组52例。
  • MRI组为2011年4月至2015年12月连续91例高级别导管原位癌患者,均在标准乳腺影像外接受术前MRI。
  • 对照组为2011年之前一段时间连续52例筛查患者,基线特征可比。
  • 比较MRI估计的高级别导管原位癌大小与最终组织学大小,并比较手术计划和手术次数。

关键影像表现/征象

  • MRI检出高级别导管原位癌的总体敏感度为77%(70/91),假阴性率23%(21/91)。
  • MRI使9例(13%)初始保乳计划正确转为乳房切除。
  • 5例(7%)发现同侧额外恶性特征,2例(3%)诊断对侧隐匿性疾病。

诊断标准与关键数值

  • MRI检出高级别导管原位癌的敏感度为77%(70/91),假阴性率为23%(21/91)。
  • 再切除或补行乳房切除率MRI组8% vs 对照组26%(P=0.012)。
  • MRI组91例中70例纳入数据分析,中位年龄63岁,70%通过筛查项目发现。

临床应用与阅片要点

  • 作者认为选择性MRI成像可能有助于高级别导管原位癌的术前诊断与评估。
  • 作者认为多学科团队逐例讨论至关重要。
  • 作者认为在有指征时更广泛地应用MRI并与术后组织学正确对照,有助于提高MRI判读能力。

局限性

  • MRI检出高级别导管原位癌的假阴性率为23%(21/91),91例中仅70例纳入数据分析。
  • 作者指出MRI的作用仍有争议。
  • 作者在结论中使用「suggests」「could be」「can be useful」等限定表述,并指出需多学科团队逐例讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: Preoperative assessment of pure Ductal Carcinoma Insitu (DCIS) is essential in the surgical planning. The role of Magnetic resonance imaging (MRI) has long been debated. The impact of MRI on the management of High Grade (HG) DCIS was assessed, whether it accurately captures the true size of this entity in comparison to conventional imaging, and, if MRI use would reduce the number of re-excision surgery.

METHOD: Ninety-one consecutive patients with HG DCIS, who were identified from a prospectively collected data at Kettering General Hospital between April 2011 and December 2015. All patients had preoperative MRI scan in addition to the standard breast imaging. This was compared to a control group of consecutive patients (n=52) which was obtained from a period just before 2011. Impact on surgical planning and number of surgeries for each patient was compared. The size of HG DCIS estimated by MRI was compared to the final histological size. Secondary outcomes included change of initial surgical plan and detection of occult contralateral breast cancer.

RESULTS: MRI group had 91 patients with median age of 63. Seventy percent of which presented through the screening program. The overall sensitivity of MRI to detect HG DCIS was 77% (70/91) with a false negative rate FNR of 23% (21/91). Therefore, 70 patients only were included in the data analysis. The control group included 52 screening patients with comparable baseline characteristics. Re-excision (or completion mastectomy) rates were higher in the control group 26% compared to 8% in the MRI group (P-value 0.012). MRI use correctly converted the initial plan of breast conservation to mastectomy in 9 patients (13%). Five patients had additional ipsilateral malignant features (7%).Occult contra lateral disease, was diagnosed in 2 patients (3%).

CONCLUSION: This study suggests that MRI could be an important tool in reducing the re-excision rates in the surgical management of HG DCIS. Although still controversial, selective MRI imaging can be useful in the preoperative diagnosis and evaluation of HG DCIS. Case by case discussion at MDT is crucial. Wider adaptation of MRI when indicated in the assessment of breast lesions with proper correlation to histology postoperatively is a key in improving our MRI interpretation skills, helping us to exploit the full scope of this useful tool.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Hajaj M, Karim A, Pascaline S, et al. Impact of MRI on high grade Ductal Carcinoma Insitu (HG DCIS) management, are we using the full scope of MRI? Eur J Radiol. 2017. PMID: 28987679. doi:10.1016/j.ejrad.2017.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。